Moolec Science (MLEC) Return on Invested Capital (2024)

Moolec Science's (MLEC) quarterly Return on Invested Capital came in at 0.0% in Q4 2024, up 422.11% quarter-over-quarter from 0.0% in Q3 2024.

Moolec Science (MLEC) Return on Invested Capital (2024) Analysis & Trends

Moolec Science has disclosed Return on Invested Capital across 1 years of filings, most recently posting 0.0% for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.01%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -0.01%
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -0.01%
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.00%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%